Obstacles to early treatment of idiopathic pulmonary fibrosis: current perspectives
Teng Moua, Jay H Ryu Department of Medicine, Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester MN, USA Abstract: Idiopathic pulmonary fibrosis is a progressive and fatal fibrotic lung disease which has seen new opportunity for drug treatment in the last several years...
Saved in:
Main Authors: | Moua T (Author), Ryu JH (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2019-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Idiopathic pulmonary fibrosis: current treatment options and critical appraisal of nintedanib
by: Bonella F, et al.
Published: (2015) -
Current and novel drug therapies for idiopathic pulmonary fibrosis
by: Adamali HI, et al.
Published: (2012) -
Pirfenidone treatment of idiopathic pulmonary fibrosis
by: Ye Gan, et al.
Published: (2011) -
Prospects for Treatment of Idiopathic Pulmonary Fibrosis
by: R. N. Mustafin
Published: (2022) -
Obstacles to Early Diagnosis and Treatment of Alpha-1 Antitrypsin Deficiency: Current Perspectives
by: Quinn M, et al.
Published: (2020)